Cargando…

Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis

Myelination by oligodendrocytes (OLs) is an important biological process essential for central nervous system (CNS) development and functions. Oligodendroglial lineage cells undergo several morphological and molecular changes at different stages of their lineage progression into myelinating OLs. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gacem, Nadjet, Nait-Oumesmar, Brahim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069894/ https://www.ncbi.nlm.nih.gov/pubmed/33918664 http://dx.doi.org/10.3390/life11040327

Ejemplares similares

Alteration of synaptic connectivity of oligodendrocyte precursor cells following demyelination
por: Sahel, Aurélia, et al.
Publicado: (2015)

Elevated In Vivo Levels of a Single Transcription Factor Directly Convert Satellite Glia into Oligodendrocyte-like Cells
por: Weider, Matthias, et al.
Publicado: (2015)

p70S6 kinase regulates oligodendrocyte differentiation and is active in remyelinating lesions
por: Benardais, Karelle, et al.
Publicado: (2022)

Hypomyelination and Oligodendroglial Alterations in a Mouse Model of Autism Spectrum Disorder
por: Graciarena, Mariana, et al.
Publicado: (2019)

The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies
por: Dulamea, Adriana Octaviana
Publicado: (2017)

Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis
por: López-Muguruza, Eneritz, et al.
Publicado: (2023)

Reduced Axon Calibre in the Associative Striatum of the Sapap3 Knockout Mouse
por: Lousada, Eliana, et al.
Publicado: (2021)

Vitamin D receptor–retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation
por: de la Fuente, Alerie Guzman, et al.
Publicado: (2015)

Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives
por: Raffaele, Stefano, et al.
Publicado: (2021)

Oligodendrocyte generation dynamics in multiple sclerosis
por: Yeung, Maggie S.Y., et al.
Publicado: (2019)

Molecular Mechanisms of Oligodendrocyte Injury in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Patel, Jilpa, et al.
Publicado: (2012)

Altered human oligodendrocyte heterogeneity in multiple sclerosis
por: Jäkel, Sarah, et al.
Publicado: (2019)

Teriflunomide Promotes Oligodendroglial 8,9-Unsaturated Sterol Accumulation and CNS Remyelination
por: Martin, Elodie, et al.
Publicado: (2021)

Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis
Publicado: (1994)

Multiple Sclerosis: Fas Signaling in Oligodendrocyte Cell Death
por: D'Souza, Sameer D., et al.
Publicado: (1996)

TMEM10 Promotes Oligodendrocyte Differentiation and is Expressed by Oligodendrocytes in Human Remyelinating Multiple Sclerosis Plaques
por: de Faria, Omar, et al.
Publicado: (2019)

Dysfunction of the oligodendrocytes in amyotrophic lateral sclerosis
por: Gong, Zhenxiang, et al.
Publicado: (2022)

Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis
por: Falcão, Ana Mendanha, et al.
Publicado: (2019)

T-cell responses to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis
por: Ewing, C., et al.
Publicado: (1998)

Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic
por: Way, Sharon W., et al.
Publicado: (2015)

Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis
por: Voskuhl, Rhonda R., et al.
Publicado: (2019)

Anti-Myelin Oligodendrocyte Glycoprotein and Human Leukocyte Antigens as Markers in Pediatric and Adolescent Multiple Sclerosis: on Diagnosis, Clinical Phenotypes, and Therapeutic Responses
por: Gontika, Maria P., et al.
Publicado: (2018)

Key role for lipids in cognitive symptoms of schizophrenia
por: Maas, Dorien A., et al.
Publicado: (2020)

Semaphorin4A Is Cytotoxic to Oligodendrocytes and Is Elevated in Microglia and Multiple Sclerosis
por: Leitner, Dominique F., et al.
Publicado: (2015)

Oligodendrocyte Lineage Cells in Chronic Demyelination of Multiple Sclerosis Optic Nerve
por: Jennings, Alison Ruth, et al.
Publicado: (2014)

Effects Mediated by Dimethyl Fumarate on In Vitro Oligodendrocytes: Implications in Multiple Sclerosis
por: Guerriero, Claudia, et al.
Publicado: (2022)

The multiple roles of myelin protein genes during the development of the oligodendrocyte
por: Fulton, Daniel, et al.
Publicado: (2010)

Neuron to Oligodendrocyte Precursor Cell Synapses: Protagonists in Oligodendrocyte Development and Myelination, and Targets for Therapeutics
por: Moura, Daniela M. S., et al.
Publicado: (2022)

Oligodendrocytes as A New Therapeutic Target in Schizophrenia: From Histopathological Findings to Neuron-Oligodendrocyte Interaction
por: Raabe, Florian J., et al.
Publicado: (2019)

New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab
por: Frau, Jessica, et al.
Publicado: (2018)

Progressive multiple sclerosis: latest therapeutic developments and future directions
por: Faissner, Simon, et al.
Publicado: (2019)

Astaxanthin Reduces Demyelination and Oligodendrocytes Death in A Rat Model of Multiple Sclerosis
por: Lotfi, Alireza, et al.
Publicado: (2021)

Purinergic Receptors on Oligodendrocyte Progenitors: Promising Targets for Myelin Repair in Multiple Sclerosis?
por: Lecca, Davide, et al.
Publicado: (2021)

Delayed Maturation of Oligodendrocyte Progenitors by Microgravity: Implications for Multiple Sclerosis and Space Flight
por: Tran, Victoria, et al.
Publicado: (2022)

Recent developments in multiple sclerosis therapeutics
por: Spain, Rebecca I, et al.
Publicado: (2009)

Axonal Control of Oligodendrocyte Development
por: Barres, Ben A., et al.
Publicado: (1999)

Oligodendrocytes in Development, Myelin Generation and Beyond
por: Kuhn, Sarah, et al.
Publicado: (2019)

Connecting Neuroinflammation and Neurodegeneration in Multiple Sclerosis: Are Oligodendrocyte Precursor Cells a Nexus of Disease?
por: Psenicka, Morgan W., et al.
Publicado: (2021)

Variation of the Myelin Oligodendrocyte Glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population
por: Marrosu, Maria Giovanna, et al.
Publicado: (2007)

A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis
por: Olsen, John A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q14pmqaofnj5lpgg20t4v6v3t1